Sloane, Peter A <br/><br/>
A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease.  [electronic resource] 

 -  PloS one  2012 
 - e39809 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0039809  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aminophenols--pharmacology<br/>Cystic Fibrosis Transmembrane Conductance Regulator--metabolism<br/>Demography<br/>Epithelial Cells--drug effects<br/>Female<br/>Humans<br/>Ion Transport--drug effects<br/>Lung Diseases--metabolism<br/>Male<br/>Membrane Potentials--drug effects<br/>Middle Aged<br/>Mucus--drug effects<br/>Quinolones--pharmacology<br/>Smoking--metabolism